NeoGenomics’ PanTracer LBx Test Qualifies for Medicare Coverage Under MolDX Policy
The blood-based genomic profiling assay for advanced solid tumors is now reimbursable under Medicare’s policy covering plasma-based genomic profiling tests.
The blood-based genomic profiling assay for advanced solid tumors is now reimbursable under Medicare’s policy covering plasma-based genomic profiling tests.
The deal positions Abbott to enter the US cancer screening and precision oncology diagnostics market with products including Cologuard and Oncotype DX tests.
The new interim CEO currently serves as senior vice president and chief operating officer at the organization.
The College of American Pathologists will begin searching for a permanent replacement while naming an interim CEO.
Read MoreThe global diagnostics manufacturer plans to transform its West Virginia sales and distribution site into a manufacturing hub for next-generation diagnostic products.
Read MoreThe diagnostics company will participate in a fireside chat on Sept 10, focusing on its in vitro diagnostic technologies.
Read MorePartnership will create 100,000-square-foot state-of-the-art laboratory facility in Southfield, with Quest managing Corewell’s 21 hospital labs statewide.
Read MoreCancer diagnostics company adds three clinical advisors and two board members to support commercial growth and platform expansion.
Read MoreLegislative investigation finds university lacked adequate controls over state appropriation for Eastern Idaho Forensic Pathology Center project.
Read MoreADLM announces new leadership appointments, with key changes to its board and executive roles.
Read MoreThe merger brings together Labguru’s data management and ELN technologies with Mosaic’s automation and orchestration capabilities.
Read MoreWhile functional medicine has long existed on the fringes of healthcare, Adam El-Hosseiny, COO of Access Medical Labs, believes it’s now moving into the mainstream.
Read MoreWaters and BD are merging BD’s Biosciences & Diagnostic Solutions unit with Waters in a $17.5 billion Reverse Morris Trust transaction.
Read MoreQuanterix Corporation has completed its acquisition of Akoya Biosciences, expanding its capabilities and market reach.
Read MoreLabcorp Whole Health Solutions is a new initiative offering specialized test panels and over 1,000 biomarkers.
Read MorebioMérieux is acquiring the assets of Day Zero Diagnostics to enhance its capabilities in NGS and rapid infectious disease diagnostics.
Read MoreAccess Medical Labs has fully transitioned to Roche Diagnostics equipment in under 30 days, increasing testing speed, capacity & efficiency.
Read MorePictor has launched its U.S. headquarters in California to expand access to its affordable, high-performance multiplex proteomics platform.
Read More